Gwynant Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Gwynant Therapeutics General Information
Description
Operator of a drug discovery company intended to focus on developing treatments for cancer and immunological disorders. The company discovers and develops small-molecule drugs that target difficult-to-treat cancers and immunological conditions with currently unmet medical needs, enabling doctors to treat patients.
Contact Information
Corporate Office
- United Kingdom
Corporate Office
- United Kingdom
Gwynant Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 14-Sep-2021 | Completed | Startup |
Gwynant Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| i2020 Accelerator | Accelerator/Incubator | Minority |
Gwynant Therapeutics FAQs
-
When was Gwynant Therapeutics founded?
Gwynant Therapeutics was founded in 2021.
-
Where is Gwynant Therapeutics headquartered?
Gwynant Therapeutics is headquartered in United Kingdom.
-
What industry is Gwynant Therapeutics in?
Gwynant Therapeutics’s primary industry is Drug Discovery.
-
Is Gwynant Therapeutics a private or public company?
Gwynant Therapeutics is a Private company.
-
What is Gwynant Therapeutics’s current revenue?
The current revenue for Gwynant Therapeutics is .
-
Who are Gwynant Therapeutics’s investors?
i2020 Accelerator has invested in Gwynant Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process